The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Enflurane-Global Market Insights and Sales Trends 2025
Synopsis
Enflurane is weaker than diethyl ether, and is generally used in combination with general anesthesia, or in combination with a variety of intravenous general anesthesia and general anesthesia.
The global Enflurane market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Enflurane in various end use industries. The expanding demands from the Medicine, Chemical Industry and Others,, are propelling Enflurane market. Pharmaceutical Grade Enflurane, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Industrial Grade Enflurane segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Enflurane market, driven by demand from China, the second largest economy with some signs of stabilising, the Enflurane market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enflurane, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enflurane market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enflurane market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enflurane sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enflurane covered in this report include Baxter, J&TEC, GE Healthcare, Gasera, Draeger and Abbott, etc.
The global Enflurane market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
J&TEC
GE Healthcare
Gasera
Draeger
Abbott
Global Enflurane market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enflurane market, Segment by Type:
Pharmaceutical Grade Enflurane
Industrial Grade Enflurane
Global Enflurane market, by Application
Medicine
Chemical Industry
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Enflurane manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Enflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Enflurane is weaker than diethyl ether, and is generally used in combination with general anesthesia, or in combination with a variety of intravenous general anesthesia and general anesthesia.
The global Enflurane market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Enflurane in various end use industries. The expanding demands from the Medicine, Chemical Industry and Others,, are propelling Enflurane market. Pharmaceutical Grade Enflurane, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Industrial Grade Enflurane segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Enflurane market, driven by demand from China, the second largest economy with some signs of stabilising, the Enflurane market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Enflurane, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Enflurane market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Enflurane market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Enflurane sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Enflurane covered in this report include Baxter, J&TEC, GE Healthcare, Gasera, Draeger and Abbott, etc.
The global Enflurane market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
J&TEC
GE Healthcare
Gasera
Draeger
Abbott
Global Enflurane market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Enflurane market, Segment by Type:
Pharmaceutical Grade Enflurane
Industrial Grade Enflurane
Global Enflurane market, by Application
Medicine
Chemical Industry
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Enflurane manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Enflurane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Enflurane Market Overview
1.1 Enflurane Product Overview
1.2 Enflurane Market Segment by Type
1.2.1 Pharmaceutical Grade Enflurane
1.2.2 Industrial Grade Enflurane
1.3 Global Enflurane Market Size by Type
1.3.1 Global Enflurane Market Size Overview by Type (2018-2029)
1.3.2 Global Enflurane Historic Market Size Review by Type (2018-2023)
1.3.3 Global Enflurane Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Enflurane Sales Breakdown by Type (2018-2023)
1.4.2 Europe Enflurane Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Enflurane Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Enflurane Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Enflurane Sales Breakdown by Type (2018-2023)
2 Global Enflurane Market Competition by Company
2.1 Global Top Players by Enflurane Sales (2018-2023)
2.2 Global Top Players by Enflurane Revenue (2018-2023)
2.3 Global Top Players by Enflurane Price (2018-2023)
2.4 Global Top Manufacturers Enflurane Manufacturing Base Distribution, Sales Area, Product Type
2.5 Enflurane Market Competitive Situation and Trends
2.5.1 Enflurane Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Enflurane Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enflurane as of 2022)
2.7 Date of Key Manufacturers Enter into Enflurane Market
2.8 Key Manufacturers Enflurane Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Enflurane Status and Outlook by Region
3.1 Global Enflurane Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Enflurane Historic Market Size by Region
3.2.1 Global Enflurane Sales in Volume by Region (2018-2023)
3.2.2 Global Enflurane Sales in Value by Region (2018-2023)
3.2.3 Global Enflurane Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Enflurane Forecasted Market Size by Region
3.3.1 Global Enflurane Sales in Volume by Region (2024-2029)
3.3.2 Global Enflurane Sales in Value by Region (2024-2029)
3.3.3 Global Enflurane Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Enflurane by Application
4.1 Enflurane Market Segment by Application
4.1.1 Medicine
4.1.2 Chemical Industry
4.1.3 Others
4.2 Global Enflurane Market Size by Application
4.2.1 Global Enflurane Market Size Overview by Application (2018-2029)
4.2.2 Global Enflurane Historic Market Size Review by Application (2018-2023)
4.2.3 Global Enflurane Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Enflurane Sales Breakdown by Application (2018-2023)
4.3.2 Europe Enflurane Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Enflurane Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Enflurane Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Enflurane Sales Breakdown by Application (2018-2023)
5 North America Enflurane by Country
5.1 North America Enflurane Historic Market Size by Country
5.1.1 North America Enflurane Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Enflurane Sales in Volume by Country (2018-2023)
5.1.3 North America Enflurane Sales in Value by Country (2018-2023)
5.2 North America Enflurane Forecasted Market Size by Country
5.2.1 North America Enflurane Sales in Volume by Country (2024-2029)
5.2.2 North America Enflurane Sales in Value by Country (2024-2029)
6 Europe Enflurane by Country
6.1 Europe Enflurane Historic Market Size by Country
6.1.1 Europe Enflurane Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Enflurane Sales in Volume by Country (2018-2023)
6.1.3 Europe Enflurane Sales in Value by Country (2018-2023)
6.2 Europe Enflurane Forecasted Market Size by Country
6.2.1 Europe Enflurane Sales in Volume by Country (2024-2029)
6.2.2 Europe Enflurane Sales in Value by Country (2024-2029)
7 Asia-Pacific Enflurane by Region
7.1 Asia-Pacific Enflurane Historic Market Size by Region
7.1.1 Asia-Pacific Enflurane Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Enflurane Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Enflurane Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Enflurane Forecasted Market Size by Region
7.2.1 Asia-Pacific Enflurane Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Enflurane Sales in Value by Region (2024-2029)
8 Latin America Enflurane by Country
8.1 Latin America Enflurane Historic Market Size by Country
8.1.1 Latin America Enflurane Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Enflurane Sales in Volume by Country (2018-2023)
8.1.3 Latin America Enflurane Sales in Value by Country (2018-2023)
8.2 Latin America Enflurane Forecasted Market Size by Country
8.2.1 Latin America Enflurane Sales in Volume by Country (2024-2029)
8.2.2 Latin America Enflurane Sales in Value by Country (2024-2029)
9 Middle East and Africa Enflurane by Country
9.1 Middle East and Africa Enflurane Historic Market Size by Country
9.1.1 Middle East and Africa Enflurane Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Enflurane Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Enflurane Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Enflurane Forecasted Market Size by Country
9.2.1 Middle East and Africa Enflurane Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Enflurane Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Information
10.1.2 Baxter Introduction and Business Overview
10.1.3 Baxter Enflurane Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Baxter Enflurane Products Offered
10.1.5 Baxter Recent Development
10.2 J&TEC
10.2.1 J&TEC Company Information
10.2.2 J&TEC Introduction and Business Overview
10.2.3 J&TEC Enflurane Sales, Revenue and Gross Margin (2018-2023)
10.2.4 J&TEC Enflurane Products Offered
10.2.5 J&TEC Recent Development
10.3 GE Healthcare
10.3.1 GE Healthcare Company Information
10.3.2 GE Healthcare Introduction and Business Overview
10.3.3 GE Healthcare Enflurane Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GE Healthcare Enflurane Products Offered
10.3.5 GE Healthcare Recent Development
10.4 Gasera
10.4.1 Gasera Company Information
10.4.2 Gasera Introduction and Business Overview
10.4.3 Gasera Enflurane Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Gasera Enflurane Products Offered
10.4.5 Gasera Recent Development
10.5 Draeger
10.5.1 Draeger Company Information
10.5.2 Draeger Introduction and Business Overview
10.5.3 Draeger Enflurane Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Draeger Enflurane Products Offered
10.5.5 Draeger Recent Development
10.6 Abbott
10.6.1 Abbott Company Information
10.6.2 Abbott Introduction and Business Overview
10.6.3 Abbott Enflurane Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Abbott Enflurane Products Offered
10.6.5 Abbott Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Enflurane Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Enflurane Industrial Chain Analysis
11.4 Enflurane Market Dynamics
11.4.1 Enflurane Industry Trends
11.4.2 Enflurane Market Drivers
11.4.3 Enflurane Market Challenges
11.4.4 Enflurane Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Enflurane Distributors
12.3 Enflurane Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
